ENTRY       D01333                      Drug
NAME        Urapidil (JP18/INN);
            Ebrantil (TN)
FORMULA     C20H29N5O3
EXACT_MASS  387.227
MOL_WEIGHT  387.476
CLASS       Cardiovascular agent
             DG01466  Adrenergic receptor antagonist
              DG01465  alpha-Adrenergic receptor antagonist
               DG01457  alpha1-Adrenergic receptor antagonist
             DG01739  Peripherally-acting antiadrenergic
             DG03231  Antihypertensive
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
REMARK      Therapeutic category: 2149 2590
            ATC code: C02CA06
            Chemical structure group: DG00257
            Product (DG00257): D01333<JP>
EFFICACY    Antidysuria, Antihypertensive, alpha1-Adrenergic receptor antagonist
TARGET      ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]
  PATHWAY   hsa04080(146+147+148)  Neuroactive ligand-receptor interaction
            hsa04261(146+147+148)  Adrenergic signaling in cardiomyocytes
            hsa04270(146+147+148)  Vascular smooth muscle contraction
METABOLISM  Enzyme: CYP2D6 [HSA:1565]
INTERACTION  
STR_MAP     map07215  alpha-Adrenergic receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C02 ANTIHYPERTENSIVES
               C02C ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING
                C02CA Alpha-adrenoreceptor antagonists
                 C02CA06 Urapidil
                  D01333  Urapidil (JP18/INN) &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               214  Antihypertensives
                2149  Others
                 D01333  Urapidil (JP18/INN)
              25  Urogenital and anal organ agents
               259  Miscellaneous
                2590  Miscellaneous
                 D01333  Urapidil (JP18/INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01465  alpha-Adrenergic receptor antagonist
                DG01457  alpha1-Adrenergic receptor antagonist
                 DG00257  Urapidil
                  D01333  Urapidil
              DG01739  Peripherally-acting antiadrenergic
               DG00257  Urapidil
                D01333  Urapidil
              DG03231  Antihypertensive
               DG00257  Urapidil
                D01333  Urapidil
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00257  Urapidil
                D01333  Urapidil
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG03231  Antihypertensive
               D01333  Urapidil
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRA1
                 D01333  Urapidil (JP18/INN) &lt;JP&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D01333  Urapidil
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D01333
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01465  alpha-Adrenergic receptor antagonist
                DG01457  alpha1-Adrenergic receptor antagonist
                 DG00257  Urapidil
              DG01739  Peripherally-acting antiadrenergic
               DG00257  Urapidil
              DG03231  Antihypertensive
               DG00257  Urapidil
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00257  Urapidil
DBLINKS     CAS: 34661-75-1
            PubChem: 7848396
            ChEBI: 32278
            LigandBox: D01333
            NIKKAJI: J19.690H
ATOM        28
            1   C8x C    17.0199  -22.1795
            2   C8x C    17.0199  -20.7792
            3   C8y C    18.2356  -20.0790
            4   C8y C    19.4442  -20.7792
            5   C8x C    19.4442  -22.1795
            6   C8x C    18.2356  -22.8797
            7   N1y N    20.6573  -20.0798
            8   C1x C    20.6560  -18.6863
            9   C1x C    21.8693  -17.9869
            10  N1y N    23.0816  -18.6881
            11  C1x C    23.0804  -20.0885
            12  C1x C    21.8672  -20.7877
            13  C1b C    24.2947  -17.9888
            14  C1b C    25.5070  -18.6898
            15  C1b C    26.7203  -17.9907
            16  N1b N    27.9325  -18.6917
            17  C8y C    29.1458  -17.9923
            18  C8x C    29.1429  -16.5921
            19  C8y C    30.3562  -15.8928
            20  N4y N    31.5685  -16.5940
            21  C8y C    31.5675  -17.9944
            22  N4y N    30.3542  -18.6936
            23  C1a C    30.3521  -20.0939
            24  O5x O    32.7796  -18.6954
            25  C1a C    32.7818  -15.8947
            26  O5x O    30.3572  -14.4924
            27  O2a O    18.2373  -18.6786
            28  C1a C    17.0553  -17.9940
BOND        30
            1    13  14 1
            2     4   7 1
            3    14  15 1
            4     1   2 2
            5    15  16 1
            6     2   3 1
            7    16  17 1
            8     3   4 2
            9     4   5 1
            10    5   6 2
            11    7   8 1
            12    8   9 1
            13   17  18 2
            14   18  19 1
            15   19  20 1
            16   20  21 1
            17   21  22 1
            18   22  17 1
            19    9  10 1
            20   22  23 1
            21   10  11 1
            22   21  24 2
            23   11  12 1
            24   20  25 1
            25   12   7 1
            26   19  26 2
            27    6   1 1
            28    3  27 1
            29   10  13 1
            30   27  28 1
///
